1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 FMT 1.2.3 Microbiome Drugs 1.2.4 Others 1.3 Market by Application 1.3.1 Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Stomach 1.3.3 Respiratory Tract 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Microbiome Therapeutics and Diagnostics Market Perspective (2017-2028) 2.2 Microbiome Therapeutics and Diagnostics Growth Trends by Region 2.2.1 Microbiome Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Microbiome Therapeutics and Diagnostics Historic Market Size by Region (2017-2022) 2.2.3 Microbiome Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) 2.3 Microbiome Therapeutics and Diagnostics Market Dynamics 2.3.1 Microbiome Therapeutics and Diagnostics Industry Trends 2.3.2 Microbiome Therapeutics and Diagnostics Market Drivers 2.3.3 Microbiome Therapeutics and Diagnostics Market Challenges 2.3.4 Microbiome Therapeutics and Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Microbiome Therapeutics and Diagnostics Players by Revenue 3.1.1 Global Top Microbiome Therapeutics and Diagnostics Players by Revenue (2017-2022) 3.1.2 Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022) 3.2 Global Microbiome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Microbiome Therapeutics and Diagnostics Revenue 3.4 Global Microbiome Therapeutics and Diagnostics Market Concentration Ratio 3.4.1 Global Microbiome Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics and Diagnostics Revenue in 2021 3.5 Microbiome Therapeutics and Diagnostics Key Players Head office and Area Served 3.6 Key Players Microbiome Therapeutics and Diagnostics Product Solution and Service 3.7 Date of Enter into Microbiome Therapeutics and Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Microbiome Therapeutics and Diagnostics Breakdown Data by Type 4.1 Global Microbiome Therapeutics and Diagnostics Historic Market Size by Type (2017-2022) 4.2 Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) 5 Microbiome Therapeutics and Diagnostics Breakdown Data by Application 5.1 Global Microbiome Therapeutics and Diagnostics Historic Market Size by Application (2017-2022) 5.2 Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Microbiome Therapeutics and Diagnostics Market Size (2017-2028) 6.2 North America Microbiome Therapeutics and Diagnostics Market Size by Type 6.2.1 North America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) 6.2.2 North America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) 6.2.3 North America Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028) 6.3 North America Microbiome Therapeutics and Diagnostics Market Size by Application 6.3.1 North America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) 6.3.2 North America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) 6.3.3 North America Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028) 6.4 North America Microbiome Therapeutics and Diagnostics Market Size by Country 6.4.1 North America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) 6.4.2 North America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Microbiome Therapeutics and Diagnostics Market Size (2017-2028) 7.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Type 7.2.1 Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) 7.2.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) 7.2.3 Europe Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028) 7.3 Europe Microbiome Therapeutics and Diagnostics Market Size by Application 7.3.1 Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) 7.3.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) 7.3.3 Europe Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028) 7.4 Europe Microbiome Therapeutics and Diagnostics Market Size by Country 7.4.1 Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) 7.4.2 Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size (2017-2028) 8.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Type 8.2.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028) 8.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Application 8.3.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028) 8.4 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region 8.4.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Microbiome Therapeutics and Diagnostics Market Size (2017-2028) 9.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Type 9.2.1 Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) 9.2.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) 9.2.3 Latin America Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028) 9.3 Latin America Microbiome Therapeutics and Diagnostics Market Size by Application 9.3.1 Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) 9.3.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) 9.3.3 Latin America Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028) 9.4 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country 9.4.1 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) 9.4.2 Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size (2017-2028) 10.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Type 10.2.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028) 10.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Application 10.3.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028) 10.4 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country 10.4.1 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 4D Pharma 11.1.1 4D Pharma Company Details 11.1.2 4D Pharma Business Overview 11.1.3 4D Pharma Microbiome Therapeutics and Diagnostics Introduction 11.1.4 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) 11.1.5 4D Pharma Recent Developments 11.2 Capsugel 11.2.1 Capsugel Company Details 11.2.2 Capsugel Business Overview 11.2.3 Capsugel Microbiome Therapeutics and Diagnostics Introduction 11.2.4 Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) 11.2.5 Capsugel Recent Developments 11.3 Gusto Global 11.3.1 Gusto Global Company Details 11.3.2 Gusto Global Business Overview 11.3.3 Gusto Global Microbiome Therapeutics and Diagnostics Introduction 11.3.4 Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) 11.3.5 Gusto Global Recent Developments 11.4 MatriSys Bioscience 11.4.1 MatriSys Bioscience Company Details 11.4.2 MatriSys Bioscience Business Overview 11.4.3 MatriSys Bioscience Microbiome Therapeutics and Diagnostics Introduction 11.4.4 MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) 11.4.5 MatriSys Bioscience Recent Developments 11.5 Pierre Fabre 11.5.1 Pierre Fabre Company Details 11.5.2 Pierre Fabre Business Overview 11.5.3 Pierre Fabre Microbiome Therapeutics and Diagnostics Introduction 11.5.4 Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) 11.5.5 Pierre Fabre Recent Developments 11.6 Sunstone Capital 11.6.1 Sunstone Capital Company Details 11.6.2 Sunstone Capital Business Overview 11.6.3 Sunstone Capital Microbiome Therapeutics and Diagnostics Introduction 11.6.4 Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) 11.6.5 Sunstone Capital Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of FMT Table 3. Key Players of Microbiome Drugs Table 4. Key Players of Others Table 5. Global Microbiome Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Microbiome Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Microbiome Therapeutics and Diagnostics Market Share by Region (2017-2022) Table 9. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Microbiome Therapeutics and Diagnostics Market Share by Region (2023-2028) Table 11. Microbiome Therapeutics and Diagnostics Market Trends Table 12. Microbiome Therapeutics and Diagnostics Market Drivers Table 13. Microbiome Therapeutics and Diagnostics Market Challenges Table 14. Microbiome Therapeutics and Diagnostics Market Restraints Table 15. Global Microbiome Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Microbiome Therapeutics and Diagnostics Revenue Share by Players (2017-2022) Table 17. Global Top Microbiome Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2021) Table 18. Ranking of Global Top Microbiome Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Microbiome Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Microbiome Therapeutics and Diagnostics Product Solution and Service Table 22. Date of Enter into Microbiome Therapeutics and Diagnostics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022) Table 26. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Microbiome Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028) Table 28. Global Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Microbiome Therapeutics and Diagnostics Revenue Share by Application (2017-2022) Table 30. Global Microbiome Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Microbiome Therapeutics and Diagnostics Revenue Share by Application (2023-2028) Table 32. North America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 62. 4D Pharma Company Details Table 63. 4D Pharma Business Overview Table 64. 4D Pharma Microbiome Therapeutics and Diagnostics Product Table 65. 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Table 66. 4D Pharma Recent Developments Table 67. Capsugel Company Details Table 68. Capsugel Business Overview Table 69. Capsugel Microbiome Therapeutics and Diagnostics Product Table 70. Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Table 71. Capsugel Recent Developments Table 72. Gusto Global Company Details Table 73. Gusto Global Business Overview Table 74. Gusto Global Microbiome Therapeutics and Diagnostics Product Table 75. Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Table 76. Gusto Global Recent Developments Table 77. MatriSys Bioscience Company Details Table 78. MatriSys Bioscience Business Overview Table 79. MatriSys Bioscience Microbiome Therapeutics and Diagnostics Product Table 80. MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Table 81. MatriSys Bioscience Recent Developments Table 82. Pierre Fabre Company Details Table 83. Pierre Fabre Business Overview Table 84. Pierre Fabre Microbiome Therapeutics and Diagnostics Product Table 85. Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Table 86. Pierre Fabre Recent Developments Table 87. Sunstone Capital Company Details Table 88. Sunstone Capital Business Overview Table 89. Sunstone Capital Microbiome Therapeutics and Diagnostics Product Table 90. Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Table 91. Sunstone Capital Recent Developments Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Global Microbiome Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028 Figure 2. FMT Features Figure 3. Microbiome Drugs Features Figure 4. Others Features Figure 5. Global Microbiome Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028 Figure 6. Stomach Case Studies Figure 7. Respiratory Tract Case Studies Figure 8. Other Case Studies Figure 9. Microbiome Therapeutics and Diagnostics Report Years Considered Figure 10. Global Microbiome Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Microbiome Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Microbiome Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028 Figure 13. Global Microbiome Therapeutics and Diagnostics Market Share by Players in 2021 Figure 14. Global Top Microbiome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Microbiome Therapeutics and Diagnostics Revenue in 2021 Figure 16. North America Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028) Figure 18. North America Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028) Figure 19. North America Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028) Figure 20. United States Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028) Figure 24. Europe Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028) Figure 25. Europe Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028) Figure 26. Germany Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Microbiome Therapeutics and Diagnostics Market Size Share by Region (2017-2028) Figure 36. China Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028) Figure 44. Latin America Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028) Figure 45. Latin America Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028) Figure 46. Mexico Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size Share by Country (2017-2028) Figure 52. Turkey Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Microbiome Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022) Figure 56. Capsugel Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022) Figure 57. Gusto Global Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022) Figure 58. MatriSys Bioscience Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022) Figure 59. Pierre Fabre Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022) Figure 60. Sunstone Capital Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

4D Pharma Capsugel Gusto Global MatriSys Bioscience Pierre Fabre Sunstone Capital